WASHINGTON D.C.: The annual price of newly-launched cancer drugs in the U.S. averaged $283,000 last year, a 53 percent increase from 2017, reported U.S. Democratic Representative Katie Porter.
In August, Reuters reported the record-high launch prices of new drugs in 2022 compared to 2021, which has driven the profits of drugmakers, and limited year-over-year price increases on existing drugs, due to pressure fro
